Tobin Schilke insider trades

Open-market stock purchases and sales by Tobin Schilke, Chief Financial & Infra. Ofcr. at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 5, 2016.

Recent trades

DateStockTradeValue
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$676K
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$6.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$4.1M
Sep 1, 2026CRNX Crinetics Pharmaceuticals, IncSold (not open market)$2.1M
Aug 20, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026CRNX Crinetics Pharmaceuticals, IncSold$266K
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—
Feb 23, 2026CRNX Crinetics Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CRNX Crinetics Pharmaceuticals, Inc: 1 sale, last Sep 1, 2026
  • RVNC Revance Therapeutics, Inc: 13 sales, last Feb 6, 2025
  • AKAO Achaogen Inc: 5 sales, last Jun 26, 2018

Get free alerts when Tobin Schilke files a new trade →